Quanterix Corp

QTRX

Company Profile

  • Business description

    Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

  • Contact

    900 Middlesex Turnpike
    BillericaMA01821
    USA

    T: +1 617 301-9400

    E: [email protected]

    https://www.quanterix.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    450

Stocks News & Analysis

stocks

Lowering profit forecasts on Aussie airlines

The impact of the oil price surge.
stocks

AI isn’t an economic moat killer, but it will disrupt industries

How we’re rethinking companies’ competitive advantages in an AI-first world.
stocks

AI lands a blow on some Aussie stocks – yet stands to benefit others

AI is reshaping ASX tech moats - but some are more insulated than others.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,552.6077.000.91%
CAC 407,726.2060.580.79%
DAX 4022,653.86273.671.22%
Dow JONES (US)46,212.10634.631.39%
FTSE 1009,894.1524.18-0.24%
HKSE24,382.47894.85-3.54%
NASDAQ21,950.34302.721.40%
Nikkei 22551,515.491,857.04-3.48%
NZX 50 Index13,002.0712.080.09%
S&P 5006,582.1975.711.16%
S&P/ASX 2008,365.9082.400.99%
SSE Composite Index3,813.28143.77-3.63%

Market Movers